Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Thyroid Neoplasms × fosbretabulin × Clear all

Phase

Status

Withdrawn 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Head and Neck Neoplasms 1

Interventions

vandetanib 1 fosbretabulin 1 fludarabine 1 combretastatin 1 aldesleukin 1 Water 1 Thyroxine 1 Thyrotropin-Releasing Hormone 1 Tea 1 Paclitaxel 1 Milk 1 Iodine-124 1 Iodine-123 1 Fluorodeoxyglucose F18 1 Docetaxel 1 DNA 1 Cyclophosphamide 1 Coffee 1 Carboplatin 1 Biopsy, Fine-Needle 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01701349 2014-05-01

FACT2

Mateon Therapeutics

Phase 3 Withdrawn

EndocrineHead & Neck

Head and Neck Neoplasms, Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡